Request Deal Involvement
GTCR-backed TerSera Therapeutics to acquire Xermelo business from Lexicon Pharmaceuticals, for $159m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
WilmerHale
pr advisors
The Harbinger Group
legal advisors
Kirkland & Ellis
debt providers
MidCap Financial Services
or
Principals
target
LEXICON PHARMACEUTICALS (XERMELO BUSINESS)
vendor
LEXICON PHARMACEUTICAL INC
bidder
GTCR LLC
bidder
TERSERA THERAPEUTICS LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite